Alzheimer’s disease, a formidable foe in the realm of neurodegenerative disorders, remains a puzzle that science is fervently trying to solve. While Alzheimer’s disease
AMA urges reconsideration of BMI as a health metric, highlighting its limitations and advocating for more comprehensive measures in patient assessments.